Member Info for Sangijuelas1

Seeing some stuff that makes me think AZN are sniffing around 4D

What results do you believe are missing?

Seems quite rude to appear out of nowhere making lurid accusations against a long term poster on the board who many here have come to get to know.

You have just destroyed any credibility you may have had.

Still waiting for an answer as to what results you feel are missing.

What results do you feel are missing?

Wasn't very shrewd investing in Forte though, was he?

Oliveira was buying in when the price was in the 30s. He took part in a placing where the price was 35p so don't know where you are getting 60p from.

Phil it's getting on for 2 years since the Blautix trial completed. They have done nothing in all that time.

They don't even know what they are going to do. Blaming the delay on the FDA just sounds like passing the buck.

I do feel very close to selling as I no longer trust the management

They reiterated the guidance in emails to various investors as late as December despite knowing that enrolment was not completed.

So we didn't get the Blautix Strategy Update and there was no preliminary data released.

No Phil they explicitly stated that they expected to release data at the end of Q4.

This would not have been possible given the time needed for dosing and then analysis of the results.

There was a corporate presentation in November I think saying end of Q4 for PC data. This guidance was confirmed in emails to investors in December.

Dosing in the PC trial takes between 6-9 weeks so how were they promising data when along with that they would have needed a certain amount of time to analyse the results?

Traders like Porky were specifically employing the list of catalysts as a reason to buy.

One of them has now been shown to be false.

I wouldn't be surprised if they get hit with a lawsuit from the ambulance chasing lawyers in the US.

This time I am angry Phil.

There needs to be an answer as to why they were promising data on a trial that hadn't even completed recruitment

Basically the shares Oliveira sold were bought by UK small speculators that thought they looked cheap.

Now they are dumping at the first sign of trouble so effectively the Oliveira shares are being sold again.

If I was Porky I would feel even more stupid given his assurances that he had received guarantees from the company that the guidance on the catalysts would definitely be met despite one of the trials not having completed recruitment.

They call it P1b because there was no need to get preliminary safety data in healthy volunteers.

It's just for 15 people.

We have been lied to

They gave assurances that they would stick to the list of catalysts as late as the beginning of December. How can they have been claiming pancreatic cancer data would be released when they hadn't completed enrolment to the trial?

The reason this is relevant is because they said the sequence of release of trial data would be
1-Asthma
2-Pancreatic cancer
3- Keytruda combo

And yet they would have known when they said this that they hadn't completed PC trial recruitment.

OK so why were they promising pancreatic cancer readout at the end of last year and the slide at the end of the presentation says they expect to complete enrollment at the end of Q1 2022?

Definitely not good

It's a shame as SNG have gone to a lot of effort but they have been beaten by the Covid mutations.

SNG have developed a drug so people don't need to go on ventilators but Omicron itself has done that already.

People are coming to understand Covid as a multi systemic disease rather than a purely respiratory one.

I actually think LBPs could turn out to be useful for Long Covid in the future

And yet Omicron affects the upper respiratory tract and is not spreading to the lungs, which is what the SNG therapeutic is targeting.

Hence the very low numbers of people on ventilators despite millions of cases over the last few weeks.

Think SNG investors could get very disappointed.

https://www.theguardian.com/world/2022/jan/02/new-studies-reinforce-belief-that-omicron-is-less-likely-to-damage-lungs